But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of ...

In the exploration of aging and health outcomes, epigenetic clocks have emerged as crucial biomarkers. Predominantly developed from data pertaining to ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

Researchers have discovered that the development of blood vessels in the mouse placenta is controlled epigenetically.

This zonation occurs in relation to the strength of the blood flow. What is the reason for this? Epigenetic mechanisms such ...

Researchers identified genes that could explain why some assisted reproductive technologies, like IVF, carry a higher risk of ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

Epigenetic modifiers, enzymes that catalyze covalent modifications on chromatin, play a pivotal role in establishing stable ...

Its lead candidate Tune-401, which aims to repress viral DNA that contributes to infection, has entered into clinical trials in New Zealand and Hong Kong.

Investors clearly appreciate the song Tune Therapeutics is singing, handing over $175 million in series B funds as the ...